Skip to content

A Randomized Controlled Trial of Home-Based Long-Term vs Inpatient Short-Term Transcranial Direct Current Stimulation for Geriatric Neuropathic Pain

A Randomized Controlled Trial of Home-Based Long-Term vs Inpatient Short-Term Transcranial Direct Current Stimulation for Geriatric Neuropathic Pain

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097091
Enrollment
Unknown
Registered
2025-02-12
Start date
2025-02-13
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropathic pain

Interventions

Home-Based Group:tDCS in home
Inpatient:tDCS in impatient

Sponsors

Huazhong University of Science and Technology Union Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Subjects who meet the diagnostic criteria for neuropathic pain following spinal cord injury, diabetic neuropathic pain, post-herpetic neuropathic pain, pain after nerve root injury, and complex regional pain syndrome; 2. Subjects who have characteristics of neuropathic pain, such as spontaneous pain, pain described as cutting, burning, electric shock-like, or numbness, and pain triggered by touch; 3. Subjects aged >=65 years, regardless of gender; 4. Subjects with a VAS score >=4 and a pain history of more than 3 months.

Exclusion criteria

Exclusion criteria: 1.Subjects with severe mental disorders who are unable to cooperate; 2.Subjects who are unable to understand the procedure or refuse to participate; 3.Subjects who have no skull defects or fractures and are not wearing metal, pacemakers, etc.; 4.Subjects who are pregnant, have mental abnormalities, or have low cognitive function; 5.Subjects with implanted metal foreign bodies in the body, such as cardiac pacemakers, vascular stents, etc.; 6.Subjects with head trauma, alcohol abuse, or drug abuse.

Design outcomes

Primary

MeasureTime frame
VAS score;Hamilton Depression Rating Scale ;

Secondary

MeasureTime frame
Treatment Adherence Scale;Health Status Score;SF-36 Health Status Score;PSQI Sleep Quality Score;Analgesic Drug Dosage;

Countries

China

Contacts

Public ContactXiang Liao

Huazhong University of Science and Technology Union Shenzhen Hospital

liaoxiang75@email.szu.edu.cn+86 137 2559 5056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026